China plays a central role in this regional trend, as the country has seen a substantial rise in percutaneous coronary ...

Misleading narratives on differential pricing of stents undermine collaborative approach: MTaI: Our Bureau, New Delhi Thursday, April 10, 2025, 08:00 Hrs [IST] The Medical Technol ...

The BRIC Interventional Cardiology Market is poised to grow by US$ 736 million from 2020 to 2026, with a steady CAGR of 5.3% during the forecast period. Includes bare metal stents, bioabsorbable ...

In a significant policy reversal, the Gujarat government has withdrawn a contentious dual pricing order for cardiac stents ...

After domestic medical device manufacturers raised serious concerns over Gujarat’s new coronary stent pricing model, which ...

The coronary stent market in India has reached a crucial milestone, with a valuation of USD 843.8 million in 2023, reflecting a transformative shift in the country’s approach to cardiovascular ...

This decision to put off the differential pricing was taken during a meeting in Gandhinagar of the governing body of the ...

The USTR has raised alarms over India's price caps on coronary stents and high customs duties on drug formulations, arguing ...

A team from the University of Birmingham have conducted a five-year trial, with almost 500 participants, assessing different methods of restoring blood flow for patients suffering severe ischaemia ...

Drug-eluting stents (DES) are used to treat heart artery blockages. Under the updated price structure notified by the state ...

The Gujarat government has stated that the move aims to ensure "cost-effectiveness while ensuring high-quality patient care" ...

Currently, all drug-eluting stents (DES), used to treat blocked heart arteries, are priced at Rs 35,000. The Indian Express ...